is semaglutide a diabetes drug Type 2 improves weight loss, blood sugar in certain Type 1 patients with obesity New diabetes drugs do not
Description
2024 Mar 12;14(1):10
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Stopping Zepbound temporarily raises important questions about weight regain, metabolic changes, and safe restart protocols
Wegovy contains semaglutide, a GLP-1 receptor agonist that works by regulating appetite and energy intake
Liraglutide (NN2211) is a long-acting GLP-1 receptor agonist used to treat type 2 diabetes and obesity (Victoza, Saxenda)
BN Nutrition-1 is a formulated supplementary sports food
